|
GS185131: GO:0044699 single-organism process
|
|
GS210484: GO:0007606 sensory perception of chemical stimulus
|
|
GS188150: GO:0009593 detection of chemical stimulus
|
|
GS135594: mean cell hemoglobin concentration QTL 1 (Chcmq1, Published QTL Chr 2)
|
|
GS201949: GO:0044699 single-organism process
|
|
GS193051: GO:0051606 detection of stimulus
|
|
GS188641: GO:0071944 cell periphery
|
|
GS135564: cytokine deficiency colitis susceptibility 3 (Cdcs3, Published QTL Chr 2)
|
|
GS169632: MP:0009447 abnormal platelet ATP level
|
|
GS199036: GO:0016298 lipase activity
|
|
GS136114: body length 1 (Lgth1, Published QTL Chr 2)
|
|
GS168559: MP:0002421 abnormal cell-mediated immunity
|
|
GS178461: GO:0009987 cellular process
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS204966: GO:0050906 detection of stimulus involved in sensory perception
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS192041: GO:0043169 cation binding
|
|
GS169733: MP:0002461 increased immunoglobulin level
|
|
GS207099: GO:0008081 phosphoric diester hydrolase activity
|
|
GS164809: MP:0004865 abnormal platelet calcium level
|
|
GS198370: GO:0042578 phosphoric ester hydrolase activity
|
|
GS162984: MP:0001800 abnormal humoral immune response
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS129192: type 2 diabetes mellitus 2 in SMXA RI mice (T2dm2sa Published QTL Chr 2)
|
|
GS168845: MP:0002459 abnormal B cell physiology
|
|
GS199635: GO:0005622 intracellular
|
|
GS190247: GO:0032403 protein complex binding
|
|
GS193268: GO:0005575 cellular_component
|
|
GS206050: GO:0031680 G-protein beta/gamma-subunit complex
|
|
GS207365: GO:0005829 cytosol
|
|
GS192429: GO:0050912 detection of chemical stimulus involved in sensory perception of taste
|
|
GS204970: GO:0050909 sensory perception of taste
|
|
GS84135: cocaine related behavior (Published QTL, Chr 2)
|
|
GS196943: GO:0008152 metabolic process
|
|
GS187146: GO:0044700 single organism signaling
|
|
GS195083: GO:0007267 cell-cell signaling
|
|
GS188108: GO:0050907 detection of chemical stimulus involved in sensory perception
|
|
GS136493: proteoglycan induced arthritis 2 (Pgia2, Published QTL Chr 2)
|
|
GS165244: MP:0010771 integument phenotype
|
|
GS196941: GO:0008150 biological_process
|
|
GS204967: GO:0050907 detection of chemical stimulus involved in sensory perception
|
|
GS208043: GO:0016788 hydrolase activity, acting on ester bonds
|
|
GS199634: GO:0005623 cell
|
|
GS167713: MP:0002417 abnormal megakaryocyte morphology
|
|
GS164136: MP:0000001 mammalian phenotype
|
|
GS197009: GO:0005886 plasma membrane
|
|
GS180296: GO:0005509 calcium ion binding
|
|
GS35916: Striatum Gene expression correlates of Handling induced convulsions 6 hrs after ethanol in Females & Males BXD
|
|
GS204007: GO:0044700 single organism signaling
|
|
GS135704: diabetes mRNA cluster 1 (Dbmc1, Published QTL Chr 2)
|
|
GS201431: GO:0005515 protein binding
|
|
GS164382: MP:0001986 abnormal taste sensitivity
|
|
GS164122: MP:0000228 abnormal thrombopoiesis
|
|
GS165615: MP:0002123 abnormal hematopoiesis
|
|
GS135237: activity response to ethanol 4 (Actre4, Published QTL Chr 2)
|
|
GS196933: GO:0065009 regulation of molecular function
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS163333: MP:0004231 abnormal calcium ion homeostasis
|
|
GS187247: GO:0060089 molecular transducer activity
|
|
GS135287: alcohol response 2 (Alcrsp2, Published QTL Chr 2)
|
|
GS193286: GO:0004620 phospholipase activity
|
|
GS136403: organ weight QTL 3 (Orgwq3, Published QTL Chr 2)
|
|
GS187160: GO:0044707 single-multicellular organism process
|
|
GS163851: MP:0001545 abnormal hematopoietic system physiology
|
|
GS191106: GO:0044464 cell part
|
|
GS136018: heart failure modifier 5 (Hrtfm5, Published QTL Chr 2)
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS199267: GO:0043234 protein complex
|
|
GS193282: GO:0004629 phospholipase C activity
|
|
GS135858: femur breaking strength 1 (Fembrs1, Published QTL Chr 2)
|
|
GS136105: lymph node cytotoxic T lymphocyte percentage 1 (Lctlp1, Published QTL Chr 2)
|
|
GS201251: GO:0044424 intracellular part
|
|
GS135670: circadian period of locomotor activity 7 (Cplaq7, Published QTL Chr 2)
|
|
GS168551: MP:0002429 abnormal blood cell morphology/development
|
|
GS136797: total body bone mineral density 2 (Tbbmd2, Published QTL Chr 2)
|
|
GS209366: GO:0050912 detection of chemical stimulus involved in sensory perception of taste
|
|
GS204612: GO:0019222 regulation of metabolic process
|
|
GS168560: MP:0002420 abnormal adaptive immunity
|
|
GS181533: GO:0046872 metal ion binding
|
|
GS189187: GO:0031683 G-protein beta/gamma-subunit complex binding
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS135418: bitterness sensitivity 1 (Bits1, Published QTL Chr 2)
|
|
GS136639: salmonella enteritidis susceptibility 7 (Ses7, Published QTL Chr 2)
|
|
GS206620: GO:0050790 regulation of catalytic activity
|
|
GS135708: diabetes susceptibility QTL 5 (Dbsq5, Published QTL Chr 2)
|
|
GS182379: GO:0004435 phosphatidylinositol phospholipase C activity
|
|
GS207686: GO:0060191 regulation of lipase activity
|
|
GS135554: CD8 memory T cell subset 3 (Cd8mts3, Published QTL Chr 2)
|
|
GS167998: MP:0002409 decreased susceptibility to infection
|
|
GS182238: GO:0016298 lipase activity
|
|
GS136735: segregation of mitochondrial DNA QTL 2 (Smdq2, Published QTL Chr 2)
|
|
GS169827: MP:0005387 immune system phenotype
|
|
GS135219: aberrant activation of B cell proliferation (Aabpr, Published QTL Chr 2)
|
|
GS205010: GO:0009593 detection of chemical stimulus
|
|
GS136115: body length 2 (Lgth2, Published QTL Chr 2)
|
|
GS190205: GO:0008081 phosphoric diester hydrolase activity
|
|
GS204608: GO:0019226 transmission of nerve impulse
|
|
GS164811: MP:0004867 decreased platelet calcium level
|
|
GS163143: MP:0009548 abnormal platelet aggregation
|
|
GS205500: GO:0071944 cell periphery
|
|
GS170748: MP:0005025 abnormal response to infection
|
|
GS197076: GO:0005509 calcium ion binding
|
|
GS167744: MP:0004209 abnormal sweet taste sensitivity
|
|
GS192290: GO:0007600 sensory perception
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS184629: GO:0005515 protein binding
|
|
GS208665: GO:0008289 lipid binding
|
|
GS209225: GO:0007600 sensory perception
|
|
GS169133: MP:0002442 abnormal leukocyte physiology
|
|
GS170506: MP:0004210 abnormal bitter taste sensitivity
|
|
GS84133: activity response to ethanol (Published QTL, Chr 2)
|
|
GS192074: GO:1901575 organic substance catabolic process
|
|
GS195559: GO:0051336 regulation of hydrolase activity
|
|
GS129086: blood glucose level 1 (Bglu1 Published QTL Chr 2)
|
|
GS163142: MP:0009549 decreased platelet aggregation
|
|
GS191728: GO:0008289 lipid binding
|
|
GS179211: GO:0007154 cell communication
|
|
GS201987: GO:0001580 detection of chemical stimulus involved in sensory perception of bitter taste
|
|
GS192265: GO:0007165 signal transduction
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS180152: GO:0065007 biological regulation
|
|
GS135685: C. trachomatis resistance QTL 1 (Ctrq1, Published QTL Chr 2)
|
|
GS203360: GO:0010863 positive regulation of phospholipase C activity
|
|
GS136950: weight gain in high growth mice 5 (Wg5, Published QTL Chr 2)
|
|
GS210227: GO:0004629 phospholipase C activity
|
|
GS204106: GO:0060089 molecular transducer activity
|
|
GS209992: GO:0051606 detection of stimulus
|
|
GS177572: GO:0016042 lipid catabolic process
|
|
GS202760: GO:0004871 signal transducer activity
|
|
GS169533: MP:0005394 taste/olfaction phenotype
|
|
GS167711: MP:0002411 decreased susceptibility to bacterial infection
|
|
GS208978: GO:0043169 cation binding
|
|
GS169732: MP:0002462 abnormal granulocyte physiology
|
|
GS202899: GO:0050877 neurological system process
|
|
GS136872: T cell ratio modifier QTL 2 (Trmq2, Published QTL Chr 2)
|
|
GS169731: MP:0002463 abnormal neutrophil physiology
|
|
GS202602: GO:0006644 phospholipid metabolic process
|
|
GS201075: GO:0005794 Golgi apparatus
|
|
GS135236: activity response to ethanol 3 (Actre3, Published QTL Chr 2)
|
|
GS164630: MP:0006298 abnormal platelet activation
|
|
GS203594: GO:0043226 organelle
|
|
GS164379: MP:0001985 abnormal gustatory system physiology
|
|
GS189185: GO:0031680 G-protein beta/gamma-subunit complex
|
|
GS36526: Neocortex Gene expression correlates of Dowel Test - Time 30 Sec in Females & Males BXD
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS189484: GO:0023052 signaling
|
|
GS209365: GO:0050913 sensory perception of bitter taste
|
|
GS167088: MP:0001212 skin lesions
|
|
GS165537: MP:0005376 homeostasis/metabolism phenotype
|
|
GS136090: lean body mass 2 (Lbm2, Published QTL Chr 2)
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS178913: GO:0042221 response to chemical stimulus
|
|
GS186744: GO:0043226 organelle
|
|
GS209960: GO:0003008 system process
|
|
GS1214: Peripheral blood gene expression in response to chronic stress in medical students
|
|
GS194309: GO:0016042 lipid catabolic process
|
|
GS202715: GO:0035637 multicellular organismal signaling
|
|
GS182835: GO:0005622 intracellular
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS135694: directional asymmetry QTL 18 (Daq18, Published QTL Chr 2)
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS168584: MP:0004720 abnormal platelet morphology
|
|
GS203482: GO:0044093 positive regulation of molecular function
|
|
GS135795: ethanol induced low dose activation 3 (Elda3, Published QTL Chr 2)
|
|
GS208021: GO:0051345 positive regulation of hydrolase activity
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS165474: MP:0002723 abnormal immune serum protein physiology
|
|
GS135918: graft-versus host disease 3 (Gvhd3, Published QTL Chr 2)
|
|
GS1255: Gene expression signature in peripheral blood cells from medical students exposed to chronic psychological stress.
|
|
GS167098: MP:0001819 abnormal immune cell physiology
|
|
GS177356: GO:0003674 molecular_function
|
|
GS210231: GO:0004620 phospholipase activity
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS197619: GO:0005543 phospholipid binding
|
|
GS207143: GO:0032403 protein complex binding
|
|
GS189860: GO:0043167 ion binding
|
|
GS164223: MP:0001209 spontaneous skin ulceration
|
|
GS167321: MP:0003945 abnormal lymphocyte physiology
|
|
GS191129: GO:0016787 hydrolase activity
|
|
GS195897: GO:0044255 cellular lipid metabolic process
|
|
GS180166: GO:0008152 metabolic process
|
|
GS206742: GO:0043167 ion binding
|
|
GS136472: periosteal circumference and femur length 2 (Pcfm2, Published QTL Chr 2)
|
|
GS184267: GO:0005794 Golgi apparatus
|
|
GS83987: cocaine related behavior 3 (Cocrb3, Published QTL, Chr 2)
|
|
GS199176: GO:0004435 phosphatidylinositol phospholipase C activity
|
|
GS189751: GO:0050794 regulation of cellular process
|
|
GS182325: GO:0051716 cellular response to stimulus
|
|
GS136445: peripheral blood stem cell response to granulocyte colony stimulating factor 1 (Pbrgcsf1, Published QTL Chr 2)
|
|
GS122052: daidzein interacting genes (MeSH:C004742) in CTD
|
|
GS136011: heart rate quantitative locus 1 (Hrq1, Published QTL Chr 2)
|
|
GS35913: Neocortex Gene expression correlates of Handling induced convulsions 4 hrs after ethanol in Males BXD
|
|
GS195082: GO:0007268 synaptic transmission
|
|
GS195668: GO:0042221 response to chemical stimulus
|
|
GS200786: GO:1900274 regulation of phospholipase C activity
|
|
GS209010: GO:1901575 organic substance catabolic process
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS128575: Ethanol induced LORR Chr# 2
|
|
GS167545: MP:0001793 altered susceptibility to infection
|
|
GS185492: GO:0050789 regulation of biological process
|
|
GS168848: MP:0002452 abnormal antigen presenting cell physiology
|
|
GS136600: serum alkaline phosphatase activity 1 (Salpa1, Published QTL Chr 2)
|
|
GS181473: GO:0005488 binding
|
|
GS129195: Tmc1 modifier 1 (Tmc1m1 Published QTL Chr 2)
|
|
GS193812: GO:0006629 lipid metabolic process
|
|
GS180036: GO:0032501 multicellular organismal process
|
|
GS196930: GO:0065007 biological regulation
|
|
GS167631: MP:0005464 abnormal platelet physiology
|
|
GS190714: GO:0016020 membrane
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS180826: GO:0005543 phospholipid binding
|
|
GS207616: GO:0016020 membrane
|
|
GS195214: GO:0009987 cellular process
|
|
GS129156: multigenic obesity QTL 5 (Mobq5 Published QTL Chr 2)
|
|
GS163934: MP:0001764 abnormal homeostasis
|
|
GS180229: GO:0005886 plasma membrane
|
|
GS199124: GO:0051716 cellular response to stimulus
|
|
GS169389: MP:0002060 abnormal skin morphology
|
|
GS136364: obesity QTL 10 (Obq10, Published QTL Chr 2)
|
|
GS167542: MP:0001790 abnormal immune system physiology
|
|
GS163933: MP:0001765 abnormal ion homeostasis
|
|
GS177094: GO:0006629 lipid metabolic process
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS167710: MP:0002410 decreased susceptibility to viral infection
|
|
GS168585: MP:0004721 abnormal platelet dense granule morphology
|
|
GS192428: GO:0050913 sensory perception of bitter taste
|
|
GS197651: GO:0007202 activation of phospholipase C activity
|
|
GS135855: femoral bone morphometry 4 (Fembm4, Published QTL Chr 2)
|
|
GS136160: leishmaniasis resistance 14 (Lmr14, Published QTL Chr 2)
|
|
GS191135: GO:0016788 hydrolase activity, acting on ester bonds
|
|
GS198263: GO:0005488 binding
|
|
GS135837: total fat pad mass QTL 1 (Fatmq1, Published QTL Chr 2)
|
|
GS84136: ethanol induced locomotion (Published QTL, Chr 2)
|
|
GS193539: GO:0007606 sensory perception of chemical stimulus
|
|
GS206355: GO:0023052 signaling
|
|
GS192918: GO:0050896 response to stimulus
|
|
GS195151: GO:0019637 organophosphate metabolic process
|
|
GS186067: GO:0050877 neurological system process
|
|
GS165418: MP:0002490 abnormal immunoglobulin level
|
|
GS209199: GO:0007165 signal transduction
|
|
GS208037: GO:0016787 hydrolase activity
|
|
GS198323: GO:0046872 metal ion binding
|
|
GS181578: GO:0042578 phosphoric ester hydrolase activity
|
|
GS193018: GO:0003008 system process
|
|
GS209235: GO:0006793 phosphorus metabolic process
|
|
GS190471: GO:0005829 cytosol
|
|
GS195977: GO:0007154 cell communication
|
|
GS207685: GO:0060193 positive regulation of lipase activity
|
|
GS135892: failure of ureteric bud invasion 1 (Fubi1, Published QTL Chr 2)
|
|
GS169767: MP:0002396 abnormal hematopoietic system morphology/development
|
|
GS184447: GO:0044424 intracellular part
|
|
GS129169: plasma plant sterol 2b (Plast2b Published QTL Chr 2)
|
|
GS207862: GO:0009056 catabolic process
|
|
GS198274: GO:0035556 intracellular signal transduction
|
|
GS135584: cholesterol absorption 1 (Chab1, Published QTL Chr 2)
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS169777: MP:0002398 abnormal bone marrow cell morphology/development
|
|
GS167717: MP:0002419 abnormal innate immunity
|
|
GS182469: GO:0043234 protein complex
|
|
GS169880: MP:0009676 abnormal hemostasis
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS180164: GO:0008150 biological_process
|
|
GS164689: MP:0009449 increased platelet ATP level
|
|
GS168995: MP:0009642 abnormal blood homeostasis
|
|
GS188111: GO:0050909 sensory perception of taste
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS167709: MP:0002413 abnormal megakaryocyte progenitor cell morphology
|
|
GS180236: GO:0032991 macromolecular complex
|
|
GS185921: GO:0004871 signal transducer activity
|
|
GS181483: GO:0035556 intracellular signal transduction
|
|
GS188107: GO:0050906 detection of stimulus involved in sensory perception
|
|
GS136527: prion disease incubation time 1 (Prdt1, Published QTL Chr 2)
|
|
GS206052: GO:0031683 G-protein beta/gamma-subunit complex binding
|
|
GS208012: GO:0044464 cell part
|
|
GS209232: GO:0006796 phosphate-containing compound metabolic process
|
|
GS210212: GO:0005575 cellular_component
|
|
GS136595: rotarod performance 2 (Rrodp2, Published QTL Chr 2)
|
|
GS185172: GO:0001580 detection of chemical stimulus involved in sensory perception of bitter taste
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS190954: GO:0009056 catabolic process
|
|
GS200867: GO:0043085 positive regulation of catalytic activity
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS135235: activity response to ethanol 2 (Actre2, Published QTL Chr 2)
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS163568: MP:0002551 abnormal blood coagulation
|
|
GS136914: vertebral morphology and mechanical traits 2 (Vmmt2, Published QTL Chr 2)
|
|
GS136873: T cell ratio modifier QTL 3 (Trmq3, Published QTL Chr 2)
|
|
GS207472: GO:0010517 regulation of phospholipase activity
|
|
GS207464: GO:0010518 positive regulation of phospholipase activity
|
|
GS166194: MP:0009931 abnormal skin appearance
|
|
GS136360: Neuroadapted Sindbis viral RNA level 1 (Nsv1, Published QTL Chr 2)
|
|
GS84132: ethanol induced locomotor activity (Published QTL, Chr 2)
|
|
GS136010: hemotopoietic response to early cytokines (Hrec, Published QTL Chr 2)
|
|
GS169535: MP:0005397 hematopoietic system phenotype
|
|
GS136055: IgA nephropathy QTL 1 (Ignpq1, Published QTL Chr 2)
|
|
GS182834: GO:0005623 cell
|